Filter posts

Defining and Communicating Value

BIO President and CEO Jim Greenwood has defined value-based agreements as an important part of …

“A Transformative Year in Medicine”

2017 will be remembered as an exciting year for biopharmaceutical innovation. Not only did we …

BIO’s Tom DiLenge Testifies on Biotechnology Innovation Ecosystem before House E&C #SubHealth

At a hearing today held by the House Energy and Commerce Subcommittee on Health on …

Celebrating 21st Century Cures One Year Later

Today marks an important day for America. It was just one year ago that the …

Five Questions for the Senate Hearing on Prescription Drugs

On Tuesday, the Senate Committee on Health, Education, Labor, and Pensions will hold its third …

ICYMI: Reducing Regulatory Hurdles Can Help Boost Innovation

Featured this week in the Wall Street Journal, columnist Greg Ip discusses how reducing regulatory hurdles …

BIO Launches New Website Holding Insurers Accountable: Un-surance.com

BIO is undertaking an aggressive effort to promote the value of biopharmaceutical innovations and ensure …

ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which …

ICYMI: Making Biopharmaceutical Innovation a Priority of the Next Administration

Last week, Astellas Americas President Jim Robinson wrote an op-ed in Forbes exploring, “How The …

8 Reasons New Medicines are Needed for Alzheimer’s

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel …